Chugai Pharmaceutical Co Ltd - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Chugai Pharmaceutical Co Ltd Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Chugai Pharmaceutical Co Ltd. The Group's principal activity is to manufacture pharmaceutical products. The products include prescription medicines for central nervous, cardiovascular, respiratory, gastrointestinal and metabolic systems, hormones and diagnostic products and OTC drugs. The operations are carried out through the following divisions: Pharmaceuticals and Other operations. The major products are epogin, alfarol, neutrogin, sigmart , suvenyl, oxarol, rocephin, renagel and rythmodan.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report